Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors-Reference-Cited by-同舟云学术

Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors

Published:2020-09-10 Issue:1 Volume:185 Page:247-253
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sollena Pietro^ORCID,Nikolaou Vasiliki,Soupos Nikolaos,Kotteas Elias,Voudouri Dimitra,Stratigos Alexandros J.,Fattore Davide,Annunziata Maria Carmela,Orlandi Armando,Di Nardo Lucia,Apalla Zoe,Deilhes Florian,Romano Maria Concetta,Fabbrocini Gabriella,Sibaud Vincent,Peris Ketty,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-020-05914-w.pdf

Reference22 articles.

1. Yan L, Rosen N, Arteaga C (2011) Targeted cancer therapies. Chin J Cancer 30(1):1–4. https://doi.org/10.5732/cjc.010.10553

2. Brahmer J, Reckamp KL, Baas P et al (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373(2):123–135. https://doi.org/10.1056/NEJMoa1504627

3. Gao JJ, Cheng J, Bloomquist E et al (2020) CDK 4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US food and drug administration pooled analysis. Lancet Oncol 21(2):250–260. https://doi.org/10.1016/S1470-2045(19)30804-6

4. Choi YJ, Li X, Hydbring P et al (2012) The requirement for cyclin D function in tumor maintenance. Cancer Cell 22(4):438–451. https://doi.org/10.1016/j.ccr.2012.09.015

5. Hortobagyi GN, Stemmer SM, Burris HA et al (2016) Ribociclib as first-line therapy for HR-positive, advanced breast cancer. N Engl J Med 375(18):1738–1748

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribociclib induced vitiligo-like lesions;Indian Journal of Dermatology, Venereology and Leprology;2024-08-30

2. Photoprotection: Current developments and controversies;Journal of the European Academy of Dermatology and Venereology;2024-06-26

3. Palbociclib-Induced Vitiligo-Like Lesions: A Report of a Challenging Case;Cureus;2024-06-13

4. Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience;Supportive Care in Cancer;2024-02-29

5. Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2− Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication;The Oncologist;2024-01-18